Envista Holdings Corp

Envista Holdings Corp

NVST · NYSE · Healthcare / Medical Instruments & Supplies

24.49USD-0.17 (-0.69%)

Price History

Full chart

Market Stats

Previous Close24.66
Open24.76
Day Range24.48 – 24.98
52-Week Range18.77 – 30.42
Volume1.79M
Market Cap3.81B
P/E (TTM)40.91
Forward P/E16.81
EPS0.58
Dividend Yield0.00%
Beta0.86
50-Day Avg26.63
200-Day Avg25.64

About

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Paul A. Keel
  • Employees12.00K
  • HeadquartersBuilding E, Brea, CA, United States, 92821-6208, USA
  • Websitehttps://envistaco.com

Leadership

  • Mr. Paul A. KeelPresident, CEO & Chairman · b. 1970
  • Mr. Eric D. HammesSenior VP & CFO · b. 1975
  • Mr. Mark E. Nance J.D.Senior VP, General Counsel & Secretary · b. 1969
  • Mr. Robert Befidi Jr.Senior VP & President of Diagnostics · b. 1975
  • Ms. Veronica AcurioSenior VP & President of Orthodontics · b. 1971
  • Mr. Coree ThomasVP & Chief Accounting Officer · b. 1978
  • Mr. Andrew ChenChief Information Officer
  • Mr. Jim GustafsonVice President of Investor Relations
  • Paul SumilasChief Compliance Officer
  • Mr. Mischa M. ReisSenior Vice President of Strategy & Corporate Development · b. 1973

Financials

Income Statement

Currency: USD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.74B2.79B2.81B2.84B2.28B1.93B2.51B2.57B2.57B2.51B2.72B
Growth (%)-+1.79%+0.92%+1.20%-19.68%-15.57%+30.06%+2.40%-0.10%-2.18%+8.32%
Cost of Revenue1.21B1.17B1.18B1.23B933.10M856.00M1.05B1.08B2.25B1.12B1.22B
Gross Profit1.52B1.61B1.63B1.61B1.35B1.07B1.46B1.49B1.44B1.39B1.50B
Gross Margin55.62%57.92%57.90%56.59%59.16%55.63%58.29%57.93%56.13%55.43%55.02%
Operating Expense1.17B1.21B1.24B1.31B1.12B1.03B1.16B1.17B1.41B2.43B1.27B
Operating Income350.00M402.80M386.60M298.40M235.70M43.50M306.20M319.20M31.50M-1.04B225.70M
Operating Margin12.79%14.46%13.75%10.49%10.32%2.25%12.20%12.42%1.23%-41.35%8.30%
EBITDA-563.30M543.90M454.80M377.00M260.20M496.00M497.70M31.50M279.50M329.80M
EBITDA Margin-20.22%19.35%15.99%16.50%13.49%19.77%19.37%1.23%11.13%12.13%
Net Income275.50M272.00M301.10M230.70M217.60M33.30M340.50M243.10M-100.20M-1.12B47.00M
Net Income Margin10.07%9.77%10.71%8.11%9.52%1.73%13.57%9.46%-3.90%-44.56%1.73%
R&D-142.80M172.40M172.00M133.10M86.70M100.50M100.10M93.80M99.10M114.00M
R&D as % of Total Revenue-5.13%6.13%6.05%5.83%4.49%4.01%3.90%3.65%3.95%4.19%
Interest Expense00003.50M62.50M54.10M38.40M63.40M46.40M36.60M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.15%3.24%2.16%1.49%2.47%1.85%1.35%

Balance Sheet

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-5.99B5.84B6.16B6.88B6.57B6.59B6.61B5.35B5.68B
Total Liabilities-998.20M1.02B2.62B3.15B2.52B2.38B2.43B2.42B2.57B
Total Equity-4.99B4.82B3.54B3.72B4.06B4.21B4.17B2.93B3.11B
Cash-00211.20M888.90M1.07B606.90M940.00M1.07B1.21B
Total Debt---1.54B1.98B1.48B1.53B1.65B1.55B1.60B
Net Debt---1.33B1.09B410.00M922.20M713.60M478.60M386.00M

Cash Flow

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow417.00M359.10M400.10M397.50M283.90M361.60M182.70M275.70M336.50M275.70M
Investing Cash Flow-59.40M-54.90M-75.50M-78.40M-69.10M262.70M-657.30M-62.40M-54.60M-51.10M
Financing Cash Flow-357.60M-304.20M-324.60M-107.70M492.50M-465.60M12.50M118.90M-103.70M-170.90M
Capital Expenditure49.10M48.90M72.20M77.80M47.70M54.70M75.70M58.20M33.80M45.30M
Free Cash Flow367.90M310.20M327.90M319.70M236.20M306.90M107.00M217.50M302.70M230.40M
Dividends Paid000-8.80M12.30M12.70M---
FCF to OCF88.23%86.38%81.95%80.43%83.20%84.87%58.57%78.89%89.96%83.57%
Dividend Paid to FCF0.00%0.00%0.00%-3.73%4.01%11.87%---

Earnings

Report DateAug 12, 2019Oct 24, 2019Jan 30, 2020May 12, 2020Jul 30, 2020Oct 29, 2020Feb 10, 2021May 5, 2021Aug 3, 2021Nov 3, 2021Feb 9, 2022May 4, 2022Aug 3, 2022Nov 3, 2022Feb 8, 2023May 3, 2023Aug 2, 2023Nov 1, 2023Feb 7, 2024May 1, 2024Aug 7, 2024Oct 30, 2024Feb 5, 2025May 1, 2025Jul 31, 2025Oct 29, 2025Feb 5, 2026May 6, 2026Aug 5, 2026Nov 4, 2026
EPS Estimate0.000.430.490.12-0.230.090.420.310.450.410.420.430.460.470.490.410.410.460.340.320.280.090.220.200.230.280.320.310.330.36
EPS Actual0.480.470.520.03-0.100.480.560.540.530.450.460.470.480.470.520.380.430.430.290.260.110.120.240.240.260.320.380.360.41-
Surprise-9.30%6.12%-75.00%56.52%433.33%33.33%74.19%17.78%9.76%9.52%9.30%4.35%0.00%6.12%-7.32%4.88%-6.52%-14.71%-18.75%-60.71%33.33%9.09%20.00%13.04%14.29%18.75%16.13%24.24%-
TimingAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-

Key Statistics & Ratios

Market Cap3.81B
Enterprise Value4.29B
Trailing P/E40.91
Forward P/E16.81
Price / Sales1.33
Price / Book1.24
EPS0.58
Book Value19.16
Revenue (TTM)2.86B
Gross Profit (TTM)1.58B
EBITDA406.20M
Profit Margin3.33%
Operating Margin10.39%
Return on Equity3.06%
Return on Assets3.23%
Shares Outstanding160.62M
Shares Float159.87M
Beta0.86
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 14 analystsTarget 30.00
  • Strong Buy
    3
  • Hold
    10
  • Strong Sell
    1

Ownership Breakdown

Institutions
120.77%
Insiders
0.59%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    17.85M11.12%
  • Ariel Investments, LLC
    9.82M6.11%
  • Dimensional Fund Advisors, Inc.
    9.57M5.96%
  • Morgan Stanley - Brokerage Accounts
    8.79M5.47%
  • Vanguard Portfolio Management, LLC
    7.57M4.71%
  • Vanguard Capital Management, LLC
    7.32M4.56%
  • Franklin Templeton Inc
    6.89M4.29%
  • Gates Capital Management Inc
    5.55M3.46%
  • State Street Corp
    5.23M3.26%
  • AllianceBernstein L.P.
    5.03M3.13%
  • Victory Capital Management Inc.
    4.49M2.80%
  • Fuller & Thaler Asset Management Inc
    3.77M2.35%
  • Geode Capital Management, LLC
    3.15M1.96%
  • American Century Companies Inc
    3.05M1.90%

Top Fund Holders

  • iShares Core S&P Mid-Cap ETF
    5.70M3.55%
  • Vanguard MStar Total Stk Mkt Idx Invest
    5.17M3.22%
  • Vanguard Small Cap Index
    3.75M2.33%
  • Ariel Fund Investor
    3.38M2.11%
  • Eaton Vance Atlanta Capital SMID-Cap I
    3.26M2.03%
  • Undiscovered Managers Behavioral Val L
    2.93M1.82%